Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Prescription of Letrozole for Uterine Myoma [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial is evaluating the prescription of letrozole for uterine fibroids (leiomyoma of the uterus) and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Letrozole (letrozole)

Snippet

Sponsor: University of California, San Francisco | Conditions: Leiomyoma, Uterine, Leiomyoma | Phase 4 | Status: RECRUITING